Axitinib as Second-line Treatment for Advanced Hepatocellular Carcinoma

This study is currently recruiting participants.
Verified April 2013 by National Taiwan University Hospital
Sponsor:
Collaborators:
Tri-Service General Hospital
Taipei Veterans General Hospital,Taiwan
Information provided by (Responsible Party):
National Taiwan University Hospital
ClinicalTrials.gov Identifier:
NCT01273662
First received: January 6, 2011
Last updated: May 1, 2013
Last verified: April 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2013
  Estimated Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)